Your browser doesn't support javascript.
loading
Are Reduced Levels of Coagulation Proteins Upon Admission Linked to COVID-19 Severity and Mortality?
Ceballos, Francisco C; Ryan, Pablo; Blancas, Rafael; Martin-Vicente, María; Vidal-Alcántara, Erick Joan; Peréz-García, Felipe; Bartolomé, Sofía; Churruca-Sarasqueta, Juan; Virseda-Berdices, Ana; Martínez-González, Oscar; Brochado-Kith, Oscar; Rava, Marta; Vilches-Medkouri, Carolina; Blanca-López, Natalia; Ramirez Martinez-Acitores, Ignacio; Moreira-Escriche, Patricia; De Juan, Carmen; Resino, Salvador; Fernández-Rodríguez, Amanda; Jiménez-Sousa, María Ángeles.
Afiliación
  • Ceballos FC; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Ryan P; Department of Infectious Diseases, Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Blancas R; Critical Care Department, Hospital Universitario del Tajo, Aranjuez, Spain.
  • Martin-Vicente M; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Vidal-Alcántara EJ; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Peréz-García F; Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
  • Bartolomé S; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Churruca-Sarasqueta J; Haematology and Haemostasis Department, University Hospital Infanta Leonor, Madrid, Spain.
  • Virseda-Berdices A; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Martínez-González O; Critical Care Department, Hospital Universitario del Tajo, Aranjuez, Spain.
  • Brochado-Kith O; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Rava M; Unit AIDS Research Network Cohort (CoRIS), National Center of Epidemiology (CNE), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Vilches-Medkouri C; Clinical Analysis Service, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
  • Blanca-López N; Allergology Department, University Hospital Infanta Leonor, Madrid, Spain.
  • Ramirez Martinez-Acitores I; Critical Care Department, Hospital Universitario del Tajo, Aranjuez, Spain.
  • Moreira-Escriche P; Department of Infectious Diseases, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • De Juan C; Department of Infectious Diseases, Hospital Universitario Severo Ochoa, Madrid, Spain.
  • Resino S; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Fernández-Rodríguez A; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
  • Jiménez-Sousa MÁ; Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain.
Front Med (Lausanne) ; 8: 718053, 2021.
Article en En | MEDLINE | ID: mdl-34660629
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: España